Insights

Key Takeaways for the Hemp Industry from the House's Draft Text for 2023 Farm Bill and DEA's Proposed Rules to Reschedule Marijuana

By Michelle Bodian
May 17, 2024

This was a big week for hemp (as well as marijuana)! The proposed rules to reschedule marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) were released and will be officially published in the federal register on May 21, 2024. Some of the language is relevant to hemp and hemp products. Additionally, the U.S. House of Representatives released draft text for the 2023 Farm Bill. Read this insight for key takeaways.

Read More

New York LLC Transparency Act Update

By Charlie Alovisetti, Daniel Molina
May 15, 2024

The New York LLC Transparency Act, which requires certain businesses to disclose ownership information to the state, was recently updated. Read this insight to learn what businesses in all industries need to know about the new law, including deadlines and penalties for noncompliance.

Read More

On the Horizon for Hemp: Pending State Regulatory Revisions and Open Comment Periods

By Casey Leaver
May 13, 2024

In the wake of changing laws and mandates for state agencies to regulate certain components of hemp licensing and production, there are a few states on the move with rules and regulations available for review or anticipated shortly. Read this insight about Kentucky’s new emergency rules, Rhode Island’s proposed definition of “consumable,” locality control over smokable hemp sales in Virginia, and more.

Read More

Raising Capital for Maryland Social Equity Cannabis Businesses

By Charles Alovisetti, Elena Markos
May 7, 2024

Maryland recently awarded cannabis business licenses to social equity applicants. If you were one of the lucky lottery winners, now it’s time to focus on raising money for your business. Read this insight for essential considerations around raising capital for Maryland social equity cannabis licensees.

Read More

WELCOME TO VICENTE INSIGHTS!

Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.

Subscribe to RSS

POPULAR TOPICS